![]() Mr John Jordon, President
Tagsys RFID, United States
|
DownloadsIf you already have access, please [Login] Access is available via an IDTechEx Market Intelligence Subscription Presentation Summary
Speaker BiographyJohn Jordon is responsible for the operations and business development of TAGSYS' business worldwide. John Jordon is a recognized traceability and supply-chain specialist, with a proven track record of starting up and growing businesses in the USA and in Europe. He has opened the Pharmaceuticals market for TAGSYS and is continuing to build strategic partnerships in various business segments. He has also initiated a scalable approach to RFID infrastructure that makes RFID applications easier to define and implement for clients across all markets. John Jordon was the founder of the Apriso business - the world leader in execution enterprise software - in Europe. Having sold and implemented the first RFID system in the US for Gemplus Tag in 1997, John is also the co-holder of a patent for automated gas cylinder tracking, based on Automated Data Collection. John Jordon also designed, and ran a plant for BOC Gases, a FT100 company in the USA, with overall engineering, operational and supply chain management responsibility. Company ProfileTAGSYS is the global leader in item-level RFID infrastructure. TAGSYS provides RFID systems and tags for end-to-end item-level tracking that automates labor-intensive processes, authenticates and safeguards goods, and enables real-time inventory and asset visibility. With a proven track record of delivering Reliable, Accurate and Secure (R.A.S.) RFID systems and tags, TAGSYS has deployed over 50 million tags and 50,000 reader systems to over 500 customers in more than 40 countries. Today, the company has distinguished itself as the leading innovator for pharmaceutical supply chain RFID security and inventory processes. With partners and customers that include monolithic brands such as Pfizer and West Pharmaceutical Services, taken together with a host of projects in various phases with a dozen more marquee brands in drug manufacturing, packaging and distribution, TAGSYS has taken a quantum leap forward in addressing the FDA's call to action in developing the epedigree. TAGSYS RFID solutions are currently being deployed in a range of highly specialized vertical markets that include pharmaceutical, fashion apparel, libraries, and textile rental. The company is headquartered in Boston, MA (USA) with offices in Doylestown, PA, France's Smart Valley and Asia (Hong Kong). More information on TAGSYS can be found at http://www.tagsysrfid.com |